Paiva J.A. , Pereira J.M. Clinical Microbiology and Infection

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Impact of infection on admission and of the process of care on mortality of patients admitted to the Intensive Care Unit: the INFAUCI study J. Gonçalves-Pereira,

Gut bacterial microbiota and obesity

I.J. Schalk Clinical Microbiology and Infection

Approach to diagnosis of infective endocarditis

S. Wagenpfeil, A. Neiss, K. Banz, P. Wutzler

Herpes zoster in non-hospitalized children

Migrant health—a cause for concern?

J. M. Pereira, R. P. Moreno, R. Matos, A. Rhodes, I. Martin-Loeches, M

J. M. Pereira, R. P. Moreno, R. Matos, A. Rhodes, I. Martin-Loeches, M

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

R. Cantón Clinical Microbiology and Infection

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

Overview of catheter-related infections with special emphasis on prevention based on educational programs P. Eggimann, D. Pittet Clinical Microbiology.

F. Rodríguez-Gómez, O. Cuevas, J. Anguita, P. Muñoz

Surveillance of Legionnaires’ disease in Austria

How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach D. Guillemot Clinical Microbiology.

Isospora belli infection in a patient with non-Hodgkin's lymphoma

Impact of infection on admission and of the process of care on mortality of patients admitted to the Intensive Care Unit: the INFAUCI study J. Gonçalves-Pereira,

Vector control: a cornerstone in the malaria elimination campaign

F.R. Gómez, E.P. de la Llave, J.M. García-Lechuz Moya

C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins

Sofie Arens, Jan Verhaegen, Ludo Verbist

Training for the infectious diseases speciality in Norway

F. Grill, P. Muñoz, R. Jofre, E. Bouza

G. Höffken Clinical Microbiology and Infection

Epidemiology of opportunistic infections in AIDS patients

Laboratory diagnosis and biosafety issues of biological warfare agents

Uncommon opportunistic fungi: new nosocomial threats

Levofloxacin in the treatment of ventilator-associated pneumonia

Mathematical modeling of Clostridium difficile infection

Metagenomics and probiotics

M. Aires-de-Sousa Clinical Microbiology and Infection

Effect of antioxidants on the immune response of Helicobacter pylori

Prevalence of colonisation with third-generation cephalosporin-resistant Enterobacteriaceae in ICU patients of Heidelberg University Hospitals H. von.

Laboratory diagnosis of Clostridium difficile disease

Recent developments in staphylococcal scalded skin syndrome

S8 – S47 and O50 – O440 Clinical Microbiology and Infection

A. Bryskier Clinical Microbiology and Infection

Pathogenesis of catheter-related infections: lessons for new designs

Community-acquired pneumonia: epidemiologic and clinical consideration

Pandemic lineages of extraintestinal pathogenic Escherichia coli

Training in infectious diseases and tropical medicine in Britain

Current experience in treating invasive zygomycosis with posaconazole

Reducing antibiotic use in influenza: challenges and rewards

J. R. Blanco, C. Gutierrez, M. Zabalza, J. Salcedo, I. Erdozain, J. A

Fibronectin concentrations in catheter sepsis

Clinical infection services—the Leiden experience

Statin use and clinical outcomes among pneumonia patients

Clinical Microbiology and Infection

W. Eugene Sanders, Christine C. Sanders

Overview of cefixime use in community-acquired infections

A. Norberg, C.E. Nord, B. Evengård Clinical Microbiology and Infection

K. Kaier, N.T. Mutters, U. Frank Clinical Microbiology and Infection

The atypical pneumonias: clinical diagnosis and importance

Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe Robert D. Fox Clinical Microbiology.

Abstracts Clinical Microbiology and Infection

New oral cephalosporins in pediatric community-acquired infections

Carratalà J. Clinical Microbiology and Infection

Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group† H. Goossens Clinical.

J.L. Balcázar Clinical Microbiology and Infection

Clinical microbiological case: thermointolerant microorganism growth in blood cultures and catheter tip M. Blasco-Navalpotro, M. Jordán, J.J. Camarena,

Joshua P. Metlay, Daniel E. Singer Clinical Microbiology and Infection

J.A. Pérez-Molina, F. Fernández Clinical Microbiology and Infection

Impact of antibiotic restrictions: the patient's perspective

Decision-making in otitis media in children, Part I: epidemiologic data and definitions for a reliable cost-effectiveness analysis Bernard Grenier Clinical.

Localized Mycobacterium avium complex infection in a patient on HAART

The future of diagnostic bacteriology

Presentation transcript:

Treatment of the afebrile patient after catheter withdrawal: drugs and duration Paiva J.A. , Pereira J.M. Clinical Microbiology and Infection Volume 8, Issue 5, Pages 290-294 (May 2002) DOI: 10.1046/j.1469-0691.2002.00410.x Copyright © 2002 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 1 ICU-acquired infections in Unidade de Cuidados Intensivos Polivalente da Urgáncia-Hospital S. Joáo-Porto, during 1999. Clinical Microbiology and Infection 2002 8, 290-294DOI: (10.1046/j.1469-0691.2002.00410.x) Copyright © 2002 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 2 Decisions about antibiotherapy. Clinical Microbiology and Infection 2002 8, 290-294DOI: (10.1046/j.1469-0691.2002.00410.x) Copyright © 2002 European Society of Clinical Infectious Diseases Terms and Conditions